Methodological issues in microdialysis sampling for pharmacokinetic studies.
about
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agentsP-glycoprotein inhibition increases the brain distribution and antidepressant-like activity of escitalopram in rodentsMiniaturization: an overview of biotechnologies for monitoring the physiology and pathophysiology of rodent animal models.Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental studyAn in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats.Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acidDrug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.How to measure drug transport across the blood-brain barrierThe neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation.The skin-blanching assay.Clinical microdialysis in skin and soft tissues: an update.Development and validation of a liquid chromatography/tandem mass spectrometry method for the quantification of flucloxacillin and cloxacillin in microdialysis samples.Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery.Doxorubicin interactions with bovine serum albumin revealed by microdialysis with on-line laser-induced fluorescence detection at subpicogram level.Microdialysis as a tool in local pharmacodynamics.Brain uptake of the drug of abuse γ-hydroxybutyric acid in rats.Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats.Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.Brain extracellular γ-hydroxybutyrate concentrations are decreased by L-lactate in rats: role in the treatment of overdosesAn investigation into the pharmacokinetics of 3-mercaptopropionic acid and development of a steady-state chemical seizure model using in vivo microdialysis and electrophysiological monitoring.On the rate and extent of drug delivery to the brain.Methods for measuring in-vivo percutaneous absorption in humans.Tissue pharmacokinetics of cefazolin in patients with lower limb infections.Evaluation of dynamic changes in interstitial fluid proteome following microdialysis probe insertion trauma in trapezius muscle of healthy women.Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye.Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetration.In vivo solid-phase microextraction for tissue bioanalysis.Application of microdialysis for pharmacokinetic-pharmacodynamic modelling.Investigation of microdialysis sampling calibration approaches for lipophilic analytes: doxorubicinPopulation Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.A Review on Microdialysis Calibration Methods: the Theory and Current Related Efforts.Determination of 5-hydroxymethyl-2-furaldehyde of crude and processed Fructus Corni in freely moving rats using in vivo microdialysis sampling and liquid chromatographyIn vitro microdialysis membrane efficiency of broad-spectrum antibiotics in combination and alone.Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainate.The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat.Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.Evidence on extracellular dopamine level in rat striatum: implications for the validity of quantitative microdialysis.The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid.Quantitative dual-probe microdialysis: evaluation of [3H]mannitol diffusion in agar and rat striatum.
P2860
Q26827380-752DF01B-AC24-4352-B9E5-C9B617054456Q30544869-79173FD6-C421-4F4A-AB12-63C0C84F4F3BQ31095403-DFB1462D-1484-4982-9EFF-78D81F2D4041Q33681531-03338C32-99F7-4976-866F-88F7F10C40D5Q33876743-57864D06-5E08-4D0E-B02F-10486EA945C4Q33890946-A1C7D0BE-B275-4B4B-ABFC-9745BEF3C51EQ33946973-3849AC72-FA7A-45C8-ADC7-0181C8BF5DF7Q33985116-38C666DC-631F-4088-A617-B67A5FD19950Q34013084-B619486C-E107-4ED8-BC87-1D796842602EQ34150267-C53B7241-45CD-46F7-80BB-CD48BC59189EQ34752069-20C5F757-A06F-47E7-A948-F993A72C70DBQ35233471-B0D033BC-2662-4B4C-BA9E-CE4E139CB369Q35364423-C11290E7-A0E0-4A2E-8A83-396AE495F76AQ35586789-1090B260-BEDF-4B8F-AE69-28B2158EBF2CQ35594859-16E268A1-216E-43D0-A175-17AD4E354A71Q35647145-3523B886-38A1-4F12-B838-CB86532D2C60Q36159042-E173B06A-EC17-4B61-945B-2774C3B90FBEQ36571957-FD664B01-8A87-4DA8-A697-DCA78CEF1DECQ36745625-54A92298-81AE-4EBA-B6C7-94CE243ABB21Q36776004-2C4CEBD4-0379-4EC3-AE94-73CF948BFD8AQ37023904-2DC2C31F-4F6A-4BC0-A628-BF2A32CAE1FFQ37236727-7C158984-F0AB-437B-BC7D-882B97FC1B71Q37263523-1F4FA41B-736F-4E8F-9E5D-9BD94988762FQ37684075-236EAEAB-F637-415F-ABB6-C13F7F951A70Q37810236-AC892207-CFB7-4730-AC35-832012231FFCQ37942267-43E93B68-D95B-4F7B-917C-9CEDF80C2663Q38061685-ADDA5BDE-5DFC-4235-8581-89D9B3ACFDB3Q38089788-19ACE0F0-2360-4570-8B0C-0E6EDB225648Q38261223-60F01E96-7BDF-4E2E-BA3A-284CE5866DC3Q38810304-A9A347C6-8233-4519-B06A-723CDB5B9D69Q38836850-07A26775-63F0-4E93-BBD9-5F9F4F9F4A7EQ40497617-063F964B-22EA-43F8-ADE5-BA559FEFA213Q40517120-4ED81246-AF6C-4718-A21A-93DD41559C90Q41249289-61DC4C35-3019-480C-A03C-21C128DB394DQ41711062-4C360208-9E6E-4469-A77B-FB0C0CB4A742Q41890379-65F31364-7EBF-4BDD-A013-BC07A3FBB00BQ41907641-2B8871F3-ADFB-4944-A5B2-5933521E822BQ42472019-CD103EE2-E2C1-49A1-8B15-9066F45EF7FBQ43069428-D6750468-D592-44C9-AD90-55810A04CD7DQ44029791-23D3DA41-8A06-45A6-9D9A-D284039F4AEC
P2860
Methodological issues in microdialysis sampling for pharmacokinetic studies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@ast
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@en
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@nl
type
label
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@ast
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@en
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@nl
prefLabel
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@ast
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@en
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@nl
P2093
P1476
Methodological issues in microdialysis sampling for pharmacokinetic studies.
@en
P2093
Breimer DD
de Boer AG
de Lange EC
P304
P356
10.1016/S0169-409X(00)00107-1
P407
P577
2000-12-01T00:00:00Z